Citi Starts Pharmaceutical Product Development (PPDI) at Buy
Tweet
Share
E-mailGet Alerts PPDI Hot Sheet
Price: $33.24 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Citi initiates coverage on Pharmaceutical Product Development (NASDAQ: PPDI) with a Buy. PT $38.00.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Shares of Pharmaceutical Product Development closed at $29.76 yesterday.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Shares of Pharmaceutical Product Development closed at $29.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy
- Alliance Global Partners Starts Marti Technologies (MRT) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
